在高血压患者中,P波峰值时间和白蛋白尿之间的关系
Ayca Arslan1, Dogan Ilıs1, Inanc Artac1
1Department of Cardiology, Kafkas University School of Medicine, Kars, Türkiye.
Postgraduate medicine
|February 19, 2026
概括
P波峰值时间 (PWPT) 与高血压患者的白蛋白尿有关. 这种心电图标记可能有助于非侵入性地检测早期损伤.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物标志物 生物标志物
背景情况:
- P波峰值时间 (PWPT) 反映了心房导电延迟,并与腹功能障碍有关.
- 专性尿症表明脏微血管损伤,并与亚临床扩张性功能障碍有关.
- 高血压是心血管和脏疾病的主要危险因素.
研究的目的:
- 为了确定PWPT是否与高血压患者的白色素尿独立相关.
- 评估PWPT在检测脏微血管干扰方面的诊断效用.
主要方法:
- 预计将招募367名高血压患者.
- 分类为白尿阳性 (>30 mg/g UACR) 和白尿阴性 (<30 mg/g UACR) 组.
- 收集和比较人口,实验室,心电图和心声图数据.
主要成果:
- 在专尿阳性组中,PWPT显著延长 (48 ± 11 ms与39 ± 9 ms相比,p < 0.001).
- 多变量分析确定PWPT是白蛋白尿的独立预测因子 (OR = 2.688,p < 0.001).
- PWPT表现出最高的分辨力 (AUC = 0.771),截止时间>42 ms.
结论:
- 在高血压患者中,PWPT与白尿独立相关.
- PWPT可以作为早期脏微血管损伤的有价值的非侵入性标志物.
- 进一步的研究可以探索PWPT在治疗患有脏病的高血压患者中的作用.
相关概念视频
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
402
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
402
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
362
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
362
01:26Nephrotic Syndrome II : Assessment and Medical Management
264
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
264
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
355
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
355
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
640
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
640
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
261
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
261